CDTX

Cidara Therapeutics, Inc.

—

No price data yet — the yfinance scanner hasn't produced bars for CDTX.

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Return	2026-01-09	RA CAPITAL MANAGEMENT, L.P.	10% owner	—Indirect	4,652,309	$221.50	$1.03B
Exercise	2026-01-09	RA CAPITAL MANAGEMENT, L.P.	10% owner	—Indirect	1,286,786	$0.0001	$128.68
Return	2026-01-07	Davarpanah Nicole Negar	Chief Medical Officer	—Direct	8,333	—	—
Return	2026-01-07	Davarpanah Nicole Negar	Chief Medical Officer	—Direct	12,553	$221.50	$2.78M
Return	2026-01-07	Ward Shane	COO & CLO	—Direct	25,083	$221.50	$5.56M

Return

RA CAPITAL MANAGEMENT, L.P.

10% owner · 2026-01-09

$1.03B

4,652,309 @ $221.50

Exercise

RA CAPITAL MANAGEMENT, L.P.

10% owner · 2026-01-09

$128.68

1,286,786 @ $0.0001

Return

Davarpanah Nicole Negar

Chief Medical Officer · 2026-01-07

—

8,333 shares

Return

Davarpanah Nicole Negar

Chief Medical Officer · 2026-01-07

$2.78M

12,553 @ $221.50

Return

Ward Shane

COO & CLO · 2026-01-07

$5.56M

25,083 @ $221.50

39 more transactions on ProFull insider transaction history is a Pro feature.